The in vitro anti-inflammatory effect of eight aporphine alkaloids isolated from the leaves of two Lauraceae plants (Pleurothyrium cinereum and Ocotea macrophylla) was evaluated through inhibition of two isozymes of cyclooxygenase (COX-1 and COX-2), 5-lipoxygenase (5-LOX), and platelet aggregation induced by PAF, AA and ADP. All alkaloids exhibited inhibitory activities against COX-2 (IC 50 25.9-116 μM range) and PAF-and AA-induced platelet aggregation, while only four and three of them were good COX-1 and 5-LOX inhibitors, respectively. (+)-N-acetyl-nornantenine 6 was the most potent COX-2, 5-LOX, AA and PAF inhibitor.
Vascular inflammation is a response from endothelial cells to vascular injury by activating the exocytosis of endothelial granules, that release pro-thrombotic and pro-inflammatory mediators into the blood, which is involved in the progression of other disorders such as atherosclerosis and thrombosis [1] [2] . The former is the common cause of ischaemic cardiovascular disease such as myocardial infarction and stroke [2] . Aspirin at low doses is usually used to treat thrombotic risk, acting as a selective inhibitor of platelet cyclooxygenase-1 (COX-1) activity, but the main limitation of the aspirin therapy is its negative gastrointestinal effect. Selective cyclooxygenase-2 (COX-2) inhibitors are effective antiinflammatory agents with lower gastrointestinal toxicity than aspirin [3] . However, some selective COX-2 inhibitors appear to increase cardiovascular risk [4] . Therefore, the search on COX inhibitory compounds with antiplatelet effects, possessing a different mechanism to that of NonSteroidal Anti-Inflammatory Drugs (NSAIDs), appeared to be a relevant way to provide protection against harmful cardiovascular events in treating inflammatory problems [5] .
An important number of Lauraceae plants, which are known to contain aporphine alkaloids, has showed antiinflammatory and anti-platelet properties [6] [7] [8] . Several aporphine alkaloids had been evaluated for their vascular properties [9] [10] [11] . Among these evaluated alkaloids, (+)-dicentrine 5 and (+)-nantenine 3 were found to be good antiplatelet and cardiovascular agents, respectively [9, [12] [13] [14] . As part of our research on the biological activity of Lauraceae metabolites, herein described is the in vitro evaluation of the antiinflammatory and anti-platelet effects through inhibition of COX-1, COX-2, 5-lipoxygenase (5-LOX) and aggregation of rabbit platelets induced by Platelet Activating Factor (PAF), arachidonic acid (AA), and adenosine diphosphate (ADP), respectively, for eight aporphine alkaloids previously isolated from two Lauraceae plants (Pleurothyrium cinereum and Ocotea macrophylla) [15] [16] . The evaluated alkaloids were thalicminine 1, dehydronantenine 2, (+)-nantenine 3, (+)-neolitsine 4, (+)-dicentrine 5, (+)-N-acetylnornantenine 6, (+)-cassythidine 7, didehydroocoteine 8. Their structures ( Figure 1 ) were established by spectroscopic ( 1 H and 13 C NMR) and spectrometric (HRMS) analyses, and the absolute configuration was previously defined by circular dichroism (CD) measurements [16] .
The in vitro abilities of the alkaloids 1-8 to inhibit the isozymes COX-1 and COX-2 (Table 1) were determined in the COX-catalyzed transformation of AA into PGH 2 , which is then reduced to PGF 2α and detected by the enzyme immunoassay (EIA) [17] . Most alkaloids showed selective activity against COX-2 at different levels (COX-2 IC 50 25.9-116 µM range). The N-substituted alkaloids (2-6 and 8) presented higher inhibitory activity (COX-2 IC 50 25.9-56.9 µM range), being the alkaloid 6 the most selective, potent COX-2 inhibitor, which possesses an N-acetyl substitution. In addition, alkaloids 4-5, having 1,2-methylenedioxi and N-methyl groups, were potent, selective COX-2 inhibitors, with a SI value of ca 4, which constitute important structural characteristics. Alkaloids 1-2 and 8, whose structures characterize by an unsaturated N-heterocyclic ring, exhibited lower COX-2 activity, but their COX-1 inhibition was higher (COX-1 IC 50 42.3-78.9 µM range), being alkaloid 1 the better COX-1 inhibitor.
The in vitro inhibitory effect of compounds 1-8 against 5-LOX (Table 1 ) was determined in the lipoxygenation reaction using a purified lipoxygenase to transform AA into hydroperoxides, which are detected and measured by addition of a chromogen [18] . All alkaloids showed low 5-LOX inhibitory activity except compound 6, whose IC 50 value was almost two times lower to that of positive control celecoxib, and almost six times to that of caffeic acid. This fact is important since alkaloid 6 appeared to be a COX-2/5-LOX dual inhibitor, contributing to the anti-inflammatory effect and gastric protection characteristic of COX-2 inhibitors, but also inhibiting COX-1-mediated platelet action and 5-LOX-mediated synthesis of harmful gastrointestinal leukotrienes [2] . Hence, dual inhibitors might be beneficial in the treatment of cardiovascular diseases, dominating the platelet-leukocyte interaction over the primary inflammatory process [2] . The oxoaporphine alkaloid 1 showed better 5-LOX inhibitory activity (IC 50 93.1 µM) than the alkaloids with an unsaturated N-heterocyclic ring 8, indicating that the C-7 carbonyl group is an important structural feature to 5-LOX inhibition. In vitro COX-2 selectivity index (IC50 COX-1/IC50 COX-2). In addition, the capability to inhibit the aggregation of rabbit platelets induced by PAF, AA and ADP was evaluated in vitro [19] (see Table 2 ). All alkaloids inhibited the platelet aggregation induced by three agonists at different levels. The unsaturated Nheterocyclic alkaloids 1-2 and 8 inhibited selectively the AA action, suggesting that the anti-platelet activity is likely originated from COX-1 inhibition. N-substituted alkaloids (2-6 and 8) exhibited higher inhibitory activity against PAF and AA. This structural characteristic was found to be relevant in platelet aggregation and COX-inhibition, as well as the presence of a 1,2-methylenedioxy group in compounds 4-5. However, the PAF-antagonism exhibited by Lauraceae alkaloids was found to be significant weaker on comparing with the anti-PAF activity of Lauraceae neolignans [20] . Nevertheless, alkaloid 6 showed a good pharmacological profile (lowest IC 50 value for COX-2, 5-LOX, AA-and PAF-induced platelet aggregation inhibition), among evaluated aporphine alkaloids. This fact indicates that 6 might be used in further studies for treating vascular inflammation and cardiovascular diseases, but further structure-activity studies and biological analyses are required to clarify the underlying mechanism and to draw unambiguous conclusions for the inhibition potential of N-acetyl aporphine alkaloids.
Anti-inflammatory activity of aporphine alkaloids [15, 16] .
Cells and reagents:
COX-(ovine) inhibitor screening and 5-LOX-(potato) inhibitor screening kits were purchased from Cayman Chemical Company, Ann Arbor, MI, USA. AA, PAF, ADP and ginkgolide B were acquired from Sigma-Aldrich. Platelet-rich plasma (PRP) was collected from blood of female White New Zealand rabbits at a body weight between 3 and 4 kg [19] .
COX-1 and COX-2 inhibition assay:
The ability of the test compounds listed in Table 1 to inhibit ovine COX-1 and COX-2 was determined using an EIA kit, according to the reported method [17] .
5-LOX screening inhibition assay:
The ability of the test compounds listed in Table 1 to inhibit potato 5-LOX were determined using an EIA kit, according to the reported method [18] .
Platelet aggregation induced by PAF, AA and ADP:
Samples of PRP were preincubated for 5 min at 37ºC with tested compounds listed in table 2 in dimethyl sulfoxide (DMSO). Aggregation was induced by the addition of 10 µL diluted PAF, AA or ADP, according to the test. The final concentration was 7.20 nM for PAF, 100 μM for AA, and 4.00 μM for ADP on PRP. Anti-platelet activity was carried out according to the reported method [19] .
Statistics:
Half-maximal inhibition concentrations (IC 50 , μM) were determined by non-linear regression analysis using the software GraphPad prism 5.00 (GraphPad software, San Diego, CA, USA).
